Outset Medical, Inc. (NASDAQ:OM) CEO Leslie Trigg Sells 65,236 Shares

Outset Medical, Inc. (NASDAQ:OM) CEO Leslie Trigg sold 65,236 shares of the company’s stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $0.80, for a total transaction of $52,188.80. Following the completion of the sale, the chief executive officer now owns 895,580 shares in the company, valued at $716,464. This represents a 6.79 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Leslie Trigg also recently made the following trade(s):

• On Monday, January 13th, Leslie Trigg sold 33,227 shares of Outset Medical stock. The stock was sold at an average price of $0.81, for a total value of $26,913.87.
• On Tuesday, January 7th, Leslie Trigg sold 10,227 shares of Outset Medical stock. The shares were sold at an average price of $1.29, for a total value of $13,192.83.
• On Friday, November 15th, Leslie Trigg sold 5,645 shares of Outset Medical stock. The stock was sold at an average price of $0.80, for a total transaction of $4,516.00.

Outset Medical Stock Performance

Outset Medical stock traded down $0.03 during midday trading on Wednesday, reaching $0.78. The stock had a trading volume of 951,459 shares, compared to its average volume of 2,184,304. The company has a quick ratio of 5.04, a current ratio of 6.49 and a debt-to-equity ratio of 4.12. The firm has a market capitalization of $40.98 million, a PE ratio of -0.28 and a beta of 2.05. Outset Medical, Inc. has a 12 month low of $0.44 and a 12 month high of $5.22. The firm’s 50-day moving average price is $1.01 and its 200 day moving average price is $1.28.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the business. Vanguard Personalized Indexing Management LLC purchased a new stake in shares of Outset Medical during the second quarter worth $49,000. Huntington National Bank raised its stake in shares of Outset Medical by 46.2% during the 3rd quarter. Huntington National Bank now owns 63,306 shares of the company’s stock valued at $43,000 after purchasing an additional 20,000 shares during the period. National Bank of Canada FI lifted its holdings in Outset Medical by 79.2% during the 3rd quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock worth $35,000 after purchasing an additional 23,164 shares in the last quarter. Squarepoint Ops LLC boosted its stake in Outset Medical by 74.1% in the 2nd quarter. Squarepoint Ops LLC now owns 80,300 shares of the company’s stock worth $309,000 after purchasing an additional 34,187 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new position in Outset Medical during the 2nd quarter valued at about $259,000.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada reissued a “sector perform” rating and issued a $3.00 price target on shares of Outset Medical in a report on Tuesday, January 7th.

Outset Medical Company Profile

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.